Factors Affecting Successful use of Erythropoietin in the Treatment of Anemia in Patients on Hemodialysis: Experience in Hajjah Region, Yemen

The use of recombinant human erythropoietin (rHuEpo) became an essential part of the treatment of anemia in patients with end stage renal failure (ESRF). Our experience at the Hajjah region, Yemen, confirms that the use of rHuEpo significantly increases the level of hemoglobin (HB) and hematocrit (H...

Full description

Bibliographic Details
Main Author: AL-Rohani Muhamed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2001-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2001;volume=12;issue=2;spage=220;epage=223;aulast=AL-Rohani